Table 5.
Ref. | Patient (n) | Study design | Treatment | Level values | Impact value | Comments | |
Liu et al[57] | AFP | 2034 | Retrospective | Resection (79.2%) NA (20.8) | High AFP levels (> 20 μg/L) | Large tumors (≥ 10 cm) | This large cohort study showed that High AFP level was associated with poor prognosis and poor clinicopathological features of HCC |
Higher vascular invasion | |||||||
Lower differentiated tumor | |||||||
Wang et al[139] | 160 | Retrospective | Resection | High AFP level (> 4000 UI/L) | Shorter median TTR | In this study, the value of AFP levels to predict recurrence is limited since only a few numbers of patients (9%) have AFP level higher than the cutoff level | |
Ma et al[58] | 108 | Retrospective | Resection | High AFP level (> 20 ng/mL) | Lower differentiated tumor | This study demonstrated the negative impact of high AFP levels on surgery benefit and the need to closely screen patients after resection for recurrence | |
Higher vascular invasion | |||||||
Higher postoperative 2-yr recurrence rate | |||||||
Lower 24-mo survival rate | |||||||
Ikai et al[59] | 12118 | Japanese nationwide | Resection | High AFP level (≥ 20 ng/mL) | Worsen OS after surgery | This large cohort study showed better outcome of patient resected for HCC in the last decade but the persistence of the negative impact of high AFP level on prognosis | |
Analysis | |||||||
Comparative study | |||||||
Vibert et al[60] | 153 | Retrospective | LT | AFP level increase > 15 μg/L per month | Lower OS | This study showed the negative impact on the outcome of AFP levels increases in patients undergoing LT | |
Lower RFS | |||||||
Higher recurrence rate | |||||||
Hakeem et al[61] | 12159 | Systemic review | LT | AFP > 1000 ng/mL (based on the majority of study included in the review) | Poorer OS | The authors stressed the poor quality of previous studies and the need for high-quality evidence on outcomes to use AFP levels as a prognostic indicator for patients undergoing LT | |
Poorer DFS | |||||||
Higher vascular invasion | |||||||
Poorer differentiated tumor | |||||||
Duvoux et al[62] | 972 | Prospective/retrospective | LT | High AFP level | Tumor recurrence | A new score model including AFP level was proposed to select patients for LT | |
Vascular invasion | |||||||
Poor differentiation |
AFP: Alpha-fetoprotein; DFS: Disease-free survival; HCC: Hepatocellular carcinoma; LT: Liver transplantation; NA: Not available; RFS: Recurrence-free survival; TTR: Time to recurrence.